Agios Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
10.12.24
/
50%
€43.80
Target price
10.12.25
€54.26
Performance (%)
-45.66%
End price
11.12.25
€23.80
Summary
This prediction ended on 11.12.25 with a price of €23.80. Massive losses of -45.66% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Agios Pharmaceuticals Inc. | -2.500% | -2.500% | -37.097% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $55.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat
In the thread Trading Agios Pharmaceuticals Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.60
01.11.24
01.11.24
€50.69
01.11.25
01.11.25
-7.88%
02.11.25
02.11.25
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.00
19.09.24
19.09.24
€49.40
19.09.25
19.09.25
-26.05%
20.09.25
20.09.25
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.40
02.08.24
02.08.24
€50.39
02.08.25
02.08.25
-25.25%
03.08.25
03.08.25
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€42.20
04.06.24
04.06.24
€48.75
04.06.25
04.06.25
-30.33%
05.06.25
05.06.25
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.80
16.02.24
16.02.24
€38.99
16.02.25
16.02.25
27.42%
17.02.25
17.02.25

